CIRCULATION, vol.135, no.7, pp.648-655, 2017 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
anticoagulants, cardiology, cardiovascular diseases, intracranial hemorrhages, stroke, thrombosis, WARFARIN, OUTCOMES, CARE
Hacettepe University Affiliated:
BACKGROUND: Stroke is a morbid and potentially mortal complication among patients hospitalized with acute medical illness. The potential of extended-duration thromboprophylaxis with the factor Xa inhibitor betrixaban to reduce the risk of stroke compared with standard-dose enoxaparin in this population was assessed in this retrospective APEX trial substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).